|
|
||||||||
The Journal of Immunology, Vol 156, Issue 4 1476-1481, Copyright © 1996 by American Association of Immunologists
ARTICLES |
S Hayashi, CC Chan, R Gazzinelli and FG Roberge
Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA.
We studied the effect of nitric oxide (NO) production on the evolution of toxoplasmosis in C57BL/6 mice. Infection was induced by i.p. injection of Toxoplasma gondii strain ME49. NO synthesis was inhibited by treatment with aminoguanidine, a structural analogue of L-arginine. The severity of infection was evaluated by histopathologic examination of the brain. In the infected mice treated for 2 wk with aminoguanidine, we observed an increase in the number of toxoplasma tachyzoites and intracellular cysts accompanied by an exacerbated inflammation of the brain tissue compared with that in controls. When spleen cells from infected mice were stimulated in culture with toxoplasma Ag, there was a marked cytotoxic effect on cells collected during the acute stage of infection and an inhibition of proliferation of the remaining viable lymphocytes. These effects were correlated with high levels of NO and PGE2 production. The suppression of NO synthesis prevented cell death and restored the lymphocyte proliferative response as well as lymphokine production. The neutralization of IFN-gamma or TNF-alpha had no effect on NO production in the cultures of infected mouse spleen cells. Cultures in which purified macrophages and lymphocytes from infected and naive mice were mixed indicated that the production of NO was dependent on lymphocyte activation. In the later stages of infection, when the production of NO was abating, preventing PGE2 secretion with indomethacin also increased the lymphocyte proliferative response. We conclude that the opposing effects of NO in toxoplasmosis, which protects against Toxoplasma gondii and at the same time limits the immune response, probably contribute to the establishment of the characteristic chronic state of host parasite equilibrium.
This article has been cited by other articles:
![]() |
X. Wang, H. Kang, T. Kikuchi, and Y. Suzuki Gamma Interferon Production, but Not Perforin-Mediated Cytolytic Activity, of T Cells Is Required for Prevention of Toxoplasmic Encephalitis in BALB/c Mice Genetically Resistant to the Disease Infect. Immun., August 1, 2004; 72(8): 4432 - 4438. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kizaki, K. Suzuki, Y. Hitomi, N. Taniguchi, D. Saitoh, K. Watanabe, K. Onoe, N. K. Day, R. A. Good, and H. Ohno Uncoupling protein 2 plays an important role in nitric oxide production of lipopolysaccharide-stimulated macrophages PNAS, July 9, 2002; 99(14): 9392 - 9397. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Khaskhely, M. Maruno, H. Uezato, A. Takamiyagi, S. T. Ramzi, K. M. A. Kasem, K.-i. Kariya, T. Toda, Y. Hashiguchi, E. A. G. Landires, et al. Low-Dose UVB Contributes to Host Resistance against Leishmania amazonensis Infection in Mice through Induction of Gamma Interferon and Tumor Necrosis Factor Alpha Cytokines Clin. Vaccine Immunol., May 1, 2002; 9(3): 677 - 686. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fujigaki, K. Saito, M. Takemura, N. Maekawa, Y. Yamada, H. Wada, and M. Seishima L-Tryptophan-L-Kynurenine Pathway Metabolism Accelerated by Toxoplasmagondii Infection Is Abolished in Gamma Interferon-Gene-Deficient Mice: Cross-Regulation between Inducible Nitric Oxide Synthase and Indoleamine-2,3-Dioxygenase Infect. Immun., February 1, 2002; 70(2): 779 - 786. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. F. Shen, D. M. Matteson, N. Tuaillon, B. K. Suedekum, R. R. Buggage, and C.-C. Chan Involvement of Apoptosis and Interferon-{gamma} in Murine Toxoplasmosis Invest. Ophthalmol. Vis. Sci., August 1, 2001; 42(9): 2031 - 2036. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kang and Y. Suzuki Requirement of Non-T Cells That Produce Gamma Interferon for Prevention of Reactivation of Toxoplasma gondii Infection in the Brain Infect. Immun., May 1, 2001; 69(5): 2920 - 2927. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-G. Fischer and G. Reichmann Brain Dendritic Cells and Macrophages/Microglia in Central Nervous System Inflammation J. Immunol., February 15, 2001; 166(4): 2717 - 2726. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kang, J. S. Remington, and Y. Suzuki Decreased Resistance of B Cell-Deficient Mice to Infection with Toxoplasma gondii Despite Unimpaired Expression of IFN-{gamma}, TNF-{alpha}, and Inducible Nitric Oxide Synthase J. Immunol., March 1, 2000; 164(5): 2629 - 2634. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Santiago, M. A. P. Oliveira, E. A. Bambirra, A. M. C. Faria, L. C. C. Afonso, L. Q. Vieira, and R. T. Gazzinelli Coinfection with Toxoplasma gondii Inhibits Antigen-Specific Th2 Immune Responses, Tissue Inflammation, and Parasitism in BALB/c Mice Infected with Leishmania major Infect. Immun., September 1, 1999; 67(9): 4939 - 4944. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Schluter, M. Deckert-Schluter, E. Lorenz, T. Meyer, M. Rollinghoff, and C. Bogdan Inhibition of Inducible Nitric Oxide Synthase Exacerbates Chronic Cerebral Toxoplasmosis in Toxoplasma gondii-Susceptible C57BL/6 Mice But Does Not Reactivate the Latent Disease in T. gondii-Resistant BALB/c Mice J. Immunol., March 15, 1999; 162(6): 3512 - 3518. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. MacFarlane, M. G. Schwacha, and T. K. Eisenstein In Vivo Blockage of Nitric Oxide with Aminoguanidine Inhibits Immunosuppression Induced by an Attenuated Strain of Salmonella typhimurium, Potentiates Salmonella Infection, and Inhibits Macrophage and Polymorphonuclear Leukocyte Influx into the Spleen Infect. Immun., February 1, 1999; 67(2): 891 - 898. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Silva, R. T. Gazzinelli, D. A. O. Silva, E. A. V. Ferro, L. H. Kasper, and J. R. Mineo Expression of Toxoplasma gondii-Specific Heat Shock Protein 70 during In Vivo Conversion of Bradyzoites to Tachyzoites Infect. Immun., August 1, 1998; 66(8): 3959 - 3963. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Deckert-Schluter, H. Bluethmann, A. Rang, H. Hof, and D. Schluter Crucial Role of TNF Receptor Type 1 (p55), But Not of TNF Receptor Type 2 (p75), in Murine Toxoplasmosis J. Immunol., April 1, 1998; 160(7): 3427 - 3436. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Fernandez-Gomez, S. Esteban, R. Gomez-Corvera, K. Zoulika, and A. Ouaissi Trypanosoma cruzi: Tc52 Released Protein-Induced Increased Expression of Nitric Oxide Synthase and Nitric Oxide Production by Macrophages J. Immunol., April 1, 1998; 160(7): 3471 - 3479. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Zhou, G. Miller, and R. A. Seder Factors Involved in Regulating Primary and Secondary Immunity to Infection with Histoplasma capsulatum: TNF-{alpha} Plays a Critical Role in Maintaining Secondary Immunity in the Absence of IFN-{gamma} J. Immunol., February 1, 1998; 160(3): 1359 - 1368. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Scharton-Kersten, G. Yap, J. Magram, and A. Sher Inducible Nitric Oxide Is Essential for Host Control of Persistent but Not Acute Infection with the Intracellular Pathogen Toxoplasma gondii J. Exp. Med., April 7, 1997; 185(7): 1261 - 1274. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |